Stay updated on Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision tag updated from v3.4.1 to v3.4.2 in the footer. This appears to be a minor metadata update with no changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. There were no changes to the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check28 days agoChange DetectedShow glossary option added; new QC metadata labels include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' are introduced, while existing labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' wording are adjusted as part of minor data presentation updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows a site revision update to v3.3.4 (replacing v3.3.3). This is a minor backend site update and does not affect study details, eligibility criteria, or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section reorganized: a single 'Locations' section now lists Córdoba, Coruña, Gran Canaria, Madrid, Navarre, Pontevedra, and Vizcaya, replacing the prior separate 'X Locations' headers. The page shows a revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.7%

- Check91 days agoChange DetectedPublications section updated to clarify that publications are voluntarily provided and may be about the results, and that PubMed-derived publications are auto-filled; the revision version is updated to v3.3.2, replacing the previous language from v3.2.0.SummaryDifference0.4%

Stay in the know with updates to Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial page.